Imperva Inc (IMPV) Shares Bought by Bank of New York Mellon Corp
Bank of New York Mellon Corp grew its stake in shares of Imperva Inc (NYSE:IMPV) by 8.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 136,025 shares of the software maker’s stock after acquiring an additional 10,627 shares during the period. Bank of New York Mellon Corp owned 0.40% of Imperva worth $6,509,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the company. Ameritas Investment Partners Inc. purchased a new stake in shares of Imperva during the first quarter worth $102,000. KCG Holdings Inc. acquired a new stake in Imperva during the first quarter valued at $201,000. US Bancorp DE boosted its position in Imperva by 142.3% during the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock valued at $221,000 after purchasing an additional 3,163 shares during the last quarter. Jane Street Group LLC purchased a new position in Imperva in the first quarter valued at about $224,000. Finally, Trexquant Investment LP purchased a new position in Imperva in the first quarter valued at about $242,000. Institutional investors and hedge funds own 92.72% of the company’s stock.
Several equities research analysts have recently issued reports on IMPV shares. ValuEngine lowered Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Monness Crespi & Hardt raised their price objective on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Evercore ISI set a $56.00 target price on shares of Imperva and gave the company a “buy” rating in a research note on Friday, July 28th. Stephens reiterated an “overweight” rating and issued a $61.00 target price (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. Finally, Susquehanna Bancshares Inc assumed coverage on shares of Imperva in a research report on Wednesday, June 7th. They issued a “positive” rating and a $60.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $52.78.
Imperva Inc (IMPV) opened at 43.40 on Monday. The stock’s 50 day moving average is $44.17 and its 200-day moving average is $45.59. The firm’s market cap is $1.47 billion. Imperva Inc has a 12 month low of $34.40 and a 12 month high of $57.24.
Imperva (NYSE:IMPV) last released its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million for the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.23) earnings per share. On average, analysts anticipate that Imperva Inc will post $0.81 earnings per share for the current fiscal year.
In related news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 2.20% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.